Verrica Pharmaceuticals (VRCA) stock
Breakaway doesn't score VRCA. It is too thinly traded for a fair Quality Score.
Follow VRCA's trial news. Pro members can get an alert when Verrica Pharmaceuticals files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. 3,191 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.
What's next for VRCA, and how long its cash lasts
Next step the company has named
Cash runway
$11.2M in cash
Dilution on the horizon
- Shelf registration (S-3, filed Mar 11, 2025)
- At-the-market share sales program (S-3, filed Mar 11, 2025)
Insiders
CMO Noah L. Rosenberg bought 6,230 shares on Aug 18. 3 more insider trades this year.
FDA dates in the next 60 days
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
- In 15 days
NRXPNRX Pharmaceuticals
NRXPPreservative-free ketamine
- In 27 days
CAPRCapricor Therapeutics
CAPRDeramiocel
- In 27 days
SVRASavara
SVRAMolgramostim
VRCA's latest filings
- 4 insider filings
- Quarterly report
- Verrica Pharmaceuticals Reports Second Quarter 2026 Financial Results
Why VRCA isn't scored
The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. VRCA trades about 56,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.
Straight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.